ALBECK MICHAEL has a total of 18 patent applications. Its first patent ever was published in 1987. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are JADO TECHNOLOGIES GMBH, BIOVAIL LAB INTERNAT BARBADOS SRL and HUNTER FLEMING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 5 | |
#3 | Israel | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Ireland | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Albeck Michael | 16 |
#2 | Sredni Benjamin | 16 |
#3 | Pavliv Leo | 3 |
#4 | Firedman Doron | 2 |
#5 | Albelk Michael | 1 |
#6 | Serdni Benjamin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009066301A2 | Methods and compositions for treating pdx virus with tellurium-containing compounds | |
WO2008032227A2 | Topical formulations of tellurium-containing compounds | |
WO2007032009A2 | Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis | |
WO2007032010A2 | Use of tellurium compounds for protection from ultra-violet radiation | |
IL176876D0 | Use of tellurium-containing compounds for treating warts | |
IL123777D0 | Immunomodulating compounds their preparation and use of same | |
US5102908A | Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives | |
US5093135A | Compounds for the induction of in vivo and in vitro production of cytokines |